It seems conceivable that exacerbated production of prostanoids and LTs under pathological conditions modulates peristaltic motility while deduced from your high activity of PGD2, PGE1, PGE2, butaprost, sulprostone, iloprost, U-46,619 and LTD4 to modify peristaltic overall performance and/or intestinal level of sensitivity to distension
It seems conceivable that exacerbated production of prostanoids and LTs under pathological conditions modulates peristaltic motility while deduced from your high activity of PGD2, PGE1, PGE2, butaprost, sulprostone, iloprost, U-46,619 and LTD4 to modify peristaltic overall performance and/or intestinal level of sensitivity to distension. as induced from the EP2 receptor agonist butaprost (1C1000 nM). The…